HPC
PFE icon

HM Payson & Co’s Pfizer PFE Stock Holding History

HM Payson & Co’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.9M Sell
453,303
-11,675
-3% -$305K 0.14% 91
2026
Q1 		$13.1M Buy
464,978
+5,047
+1% +$134K 0.19% 84
2025
Q4 		$11.5M Sell
459,931
-15,626
-3% -$394K 0.16% 82
2025
Q3 		$12.1M Sell
475,557
-23,204
-5% -$573K 0.17% 75
2025
Q2 		$12.1M Sell
498,761
-27,123
-5% -$633K 0.19% 73
2025
Q1 		$13.3M Sell
525,884
-38,767
-7% -$1.01M 0.23% 71
2024
Q4 		$15M Sell
564,651
-69,479
-11% -$1.88M 0.25% 69
2024
Q3 		$18.4M Sell
634,130
-24,780
-4% -$723K 0.31% 67
2024
Q2 		$18.4M Buy
658,910
+20,139
+3% +$554K 0.33% 61
2024
Q1 		$17.7M Sell
638,771
-81,244
-11% -$2.25M 0.33% 66
2023
Q4 		$20.7M Sell
720,015
-96,625
-12% -$2.92M 0.43% 55
2023
Q3 		$27.1M Sell
816,640
-74,796
-8% -$2.64M 0.64% 47
2023
Q2 		$32.7M Sell
891,436
-769,617
-46% -$30M 0.73% 44
2023
Q1 		$67.8M Sell
1,661,053
-221,097
-12% -$9.55M 1.63% 19
2022
Q4 		$96.4M Buy
1,882,150
+38,584
+2% +$1.85M 2.4% 8
2022
Q3 		$80.7M Buy
1,843,566
+24,168
+1% +$1.17M 2.21% 9
2022
Q2 		$95.4M Buy
1,819,398
+79,488
+5% +$4.05M 2.45% 5
2022
Q1 		$90.1M Buy
1,739,910
+63,874
+4% +$3.31M 2.05% 10
2021
Q4 		$99M Buy
1,676,036
+39,941
+2% +$1.98M 2.15% 8
2021
Q3 		$70.4M Buy
1,636,095
+6,846
+0.4% +$303K 1.71% 15
2021
Q2 		$63.8M Buy
1,629,249
+7,218
+0.4% +$281K 1.56% 18
2021
Q1 		$58.8M Sell
1,622,031
-17,663
-1% -$627K 1.56% 15
2020
Q4 		$60.4M Sell
1,639,694
-80,280
-5% -$2.94M 1.67% 15
2020
Q3 		$59.9M Buy
1,719,974
+79,352
+5% +$2.78M 1.84% 10
2020
Q2 		$50.9M Buy
1,640,622
+18,349
+1% +$623K 1.71% 16
2020
Q1 		$50.2M Sell
1,622,273
-98,745
-6% -$3.36M 1.97% 10
2019
Q4 		$64M Buy
1,721,018
+35,093
+2% +$1.25M 2.05% 6
2019
Q3 		$57.5M Buy
1,685,925
+94,782
+6% +$3.45M 2.02% 7
2019
Q2 		$65.4M Buy
1,591,143
+6,599
+0.4% +$262K 2.35% 4
2019
Q1 		$63.8M Buy
1,584,544
+1,564,774
+7,915% +$62.7M 2.44% 5
2018
Q4 		$819K Sell
19,770
-1,310,823
-99% -$54.4M 2.4% 10
2018
Q3 		$55.6M Sell
1,330,593
-238,388
-15% -$9.18M 2.49% 5
2018
Q2 		$54M Buy
1,568,981
+2,344
+0.1% +$80.1K 2.31% 8
2018
Q1 		$52.8M Sell
1,566,637
-10,377
-0.7% -$357K 2.18% 8
2017
Q4 		$54.2M Buy
1,577,014
+362
+0% +$12.3K 2.18% 9
2017
Q3 		$53.4M Sell
1,576,652
-10,606
-0.7% -$341K 2.3% 7
2017
Q2 		$50.6M Sell
1,587,258
-726
-0% -$22.9K 2.28% 7
2017
Q1 		$51.5M Buy
1,587,984
+34,262
+2% +$1.08M 2.35% 6
2016
Q4 		$47.9M Buy
1,553,722
+54,192
+4% +$1.65M 2.28% 6
2016
Q3 		$48.2M Buy
1,499,530
+30,680
+2% +$1.03M 2.35% 5
2016
Q2 		$49.1M Buy
1,468,850
+14,486
+1% +$462K 2.45% 4
2016
Q1 		$40.9M Buy
1,454,364
+27,651
+2% +$790K 2.13% 9
2015
Q4 		$43.7M Buy
1,426,713
+104,361
+8% +$3.28M 2.25% 6
2015
Q3 		$39.4M Buy
1,322,352
+21,242
+2% +$681K 2.14% 6
2015
Q2 		$41.4M Buy
1,301,110
+555
+0% +$18.1K 2.06% 8
2015
Q1 		$42.9M Sell
1,300,555
-57,247
-4% -$1.82M 2.15% 8
2014
Q4 		$40.1M Sell
1,357,802
-1,775
-0.1% -$50.9K 1.99% 10
2014
Q3 		$38.1M Buy
1,359,577
+119,480
+10% +$3.35M 1.95% 11
2014
Q2 		$34.9M Buy
1,240,097
+30,423
+3% +$867K 1.79% 13
2014
Q1 		$36.9M Sell
1,209,674
-5,783
-0.5% -$172K 1.95% 11
2013
Q4 		$35.3M Buy
1,215,457
+3,919
+0.3% +$114K 1.89% 12
2013
Q3 		$33M Sell
1,211,538
-7,737
-0.6% -$211K 1.91% 11
2013
Q2 		$32.4M Buy
+1,219,275
New +$33.7M 1.94% 11

Other funds holding PFE

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
KC
Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

HM Payson & Co's PFE Position: Q2 2026 in Review

HM Payson & Co reduced its Pfizer (PFE) stake by 2.5% in Q2 2026, selling an estimated $305K and leaving 453,303 shares worth $10.9M. The position accounts for 0.14% of the portfolio, ranked #91.

HM Payson & Co first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $99M in Q4 2021. 557 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • HM Payson & Co held 453,303 shares of Pfizer worth $10.9M as of Q2 2026.
  • HM Payson & Co sold 11,675 Pfizer shares in Q2 2026, an estimated $305K.
  • Pfizer made up 0.14% of HM Payson & Co's portfolio in Q2 2026, its #91 holding.
  • HM Payson & Co first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • HM Payson & Co's Pfizer position peaked at $99M in Q4 2021.
  • 557 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.